Abstract
Global Health Organizations and Scientific Societies, have set Human Papillomavirus (HPV) elimination as a public health priority. Vaccination is among the most effective measures to prevent Human papillomavirus (HPV) infection. The present study assessed the cost-effectiveness of gender-neutral vaccination (GNV) with Gardasil 9(G9) versus female only vaccination (FOV) with Gardasil 9 in Greece.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Paper Title
Journal
Date
